Cardiovascular and Neurological Conditions: A Review
Angina
Substernal pain caused by insufficient perfusion of the myocardium.
Angina Types
- Stable: Oxygen demand exceeds supply, usually brought on by physical exertion.
- Drug therapy: SL NTG, BB, or LA nitrate
- Variant: Oxygen supply decreases due to vasospasm, may occur at rest.
- Calcium channel blocker
- Unstable: Oxygen supply decreases as demand increases; secondary to atherosclerotic plaque rupture within the coronary artery.
- Combination e.g. CCB + BB
Drugs Used in Angina Pectoris
Vasodilators
Nitrates
Short,
Read MoreCardiac Measurements, ECG Findings, and Heart Conditions
Cardiac Measurements and Normal Values
This section provides normal values for various cardiac measurements obtained during echocardiography.
- KSGDD (LV): N (Upper limit): 56
- Indskas: N (Upper limit): 29
- TSP (Interventricular Septum): N: 9-10
- KSUS (Posterior Wall): N: 9-10
- KS MM (LV): M: 105, W: 95
- Mass Index: M: 105, W: 95
- SSS (Relative Wall Thickness): [Table Data Missing – Requires Calculation]
|
ECG Interpretation and Cardiovascular Management Essentials
ECG Interpretation and Cardiovascular Management
ECG Lead Locations and Waveform Analysis
- II, III, aVF: Inferior leads
- V1 & V2: Septal leads
- V3 & V4: Anterior leads
- I, aVL, V5 & V6: Lateral leads
Electrode Placement
RA (White), LA (Black), V (Brown)
Intervals and Segments
- PR Interval: 0.12-0.20 seconds
- Shorter PR: Impulse from AV junction
- Longer PR: First-degree AV block
- QRS Interval: 0.06-0.12 seconds
- QT Interval: 0.39-0.43 seconds (Predisposes to Torsades de Pointes, intensified by low calcium
Pharmacology Quick Reference: Anticoagulants, Anemia, and Antiarrhythmics
Anticoagulants
Unfractionated Heparin (UFH)
- Mechanism: Antithrombin III, Xa/IIa
- Dosage:
- Loading dose & continuous infusion: 80 units/kg load, 18 units/kg/h infusion
- Prophylaxis: 5000 units subcutaneously
- Contraindications: HIT (Heparin-Induced Thrombocytopenia), hypersensitivity, thrombocytopenia, active bleeding or risk of bleeding
- Monitoring: aPTT (activated Partial Thromboplastin Time), baseline and every 6 hours until 2x therapeutic level; goal 1.5-2.5x baseline
- Reversal Agent: Protamine sulfate